Legal Representation
Attorney
Faustino A. Lichauco
USPTO Deadlines
Application History
19 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 27, 2012 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Jul 27, 2012 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | Loading... |
| Dec 20, 2011 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Dec 20, 2011 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Dec 20, 2011 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Dec 7, 2011 | RCCK | S | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | Loading... |
| Dec 6, 2011 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Jun 6, 2011 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Jun 6, 2011 | GNSL | S | LETTER OF SUSPENSION E-MAILED | Loading... |
| Jun 6, 2011 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| Jun 1, 2011 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED | Loading... |
| Jun 1, 2011 | AMPX | O | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | Loading... |
| May 18, 2011 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| May 18, 2011 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| May 18, 2011 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| May 17, 2011 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 23, 2011 | MPMK | O | NOTICE OF PSEUDO MARK MAILED | Loading... |
| Feb 22, 2011 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Feb 19, 2011 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
pharmaceuticals for use in treatment of seizures, hypertension, cardiovascular disease, disease of the endocrine system, gastroenterological disease, hematological disease, infectious disease, disease of the immune system, musculoskeletal disease, kidney disease, disease of the nervous system, gynecological disease, cancer, diseases of the eye, ear, nose and throat, mental illness, rheumatological disease, bone disease, skin wounds, contact dermatitis, headaches, migraine headaches, muscle pain, inflammation, and for use in dental, cosmetic, maxillofacial, and plastic surgery, all available as tablets, capsules, softgels, liquids, creams, and powders; nutritional supplements available as tablets, capsules, softgels, liquids, creams, and powders
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Pseudo Mark
INSPIRE
Classification
International Classes
005